0 false false false false false false false false false false true false false false false false false No description of principal activity 2025-05-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 14070763 2025-05-01 2026-04-30 14070763 2026-04-30 14070763 2025-04-30 14070763 2024-05-01 2025-04-30 14070763 2025-04-30 14070763 2024-04-30 14070763 bus:Director1 2025-05-01 2026-04-30 14070763 core:WithinOneYear 2026-04-30 14070763 core:WithinOneYear 2025-04-30 14070763 bus:Micro-entities 2025-05-01 2026-04-30 14070763 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 14070763 bus:SmallCompaniesRegimeForAccounts 2025-05-01 2026-04-30 14070763 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 14070763 bus:FullAccounts 2025-05-01 2026-04-30
COMPANY REGISTRATION NUMBER: 14070763
MedeSurg UK Limited
Filleted Unaudited Financial Statements
For the Year Ended
30 April 2026
MedeSurg UK Limited
Statement of Financial Position
30 April 2026
2026
2025
£
£
Fixed assets
102
382
----
----
Current assets
51,811
49,296
Prepayments and accrued income
415
1,111
---------
---------
52,226
50,407
Creditors: amounts falling due within one year
2,899
1,640
---------
---------
Net Current Assets
49,327
48,767
---------
---------
Total Assets Less Current Liabilities
49,429
49,149
Accruals and deferred income
1,390
1,323
---------
---------
48,039
47,826
---------
---------
Capital and reserves
48,039
47,826
---------
---------
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 8 September 2026 , and are signed on behalf of the board by:
Dr N Ahmad
Director
Company registration number: 14070763
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 4 Nightingale Close, Scunthorpe, England, DN15 8JA.